Citations (22)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Tun-Jen Hsiao, Lawrence Shih-Hsin Wu, Shih-Yi Huang & Eugene Lin. (2010) A common variant in the adiponectin gene on weight loss and body composition under sibutramine therapy in obesity. Clinical Pharmacology: Advances and Applications 2, pages 105-110.
Read now
Read now
Victoria Salem & Stephen R Bloom. (2010) Approaches to the pharmacological treatment of obesity. Expert Review of Clinical Pharmacology 3:1, pages 73-88.
Read now
Read now
Konstantinos Tziomalos, Gerasimos E Krassas & Themistoklis Tzotzas. (2009) The use of sibutramine in the management of obesity and related disorders: An update. Vascular Health and Risk Management 5, pages 441-452.
Read now
Read now
David R Janero & Alexandros Makriyannis. (2009) Cannabinoid receptor antagonists: pharmacological opportunities, clinical experience, and translational prognosis. Expert Opinion on Emerging Drugs 14:1, pages 43-65.
Read now
Read now
Articles from other publishers (18)
Sumit Kumar Mandal, Banoth Karan Kumar, Pankaj Kumar Sharma, Sankaranarayanan Murugesan & P.R. Deepa. (2022) In silico and in vitro analysis of PPAR – α / γ dual agonists: Comparative evaluation of potential phytochemicals with anti-obesity drug orlistat. Computers in Biology and Medicine 147, pages 105796.
Crossref
Crossref
Dan Osei Mensah Bonsu, Constance Afoakwah & Maria de la Paz Aguilar-Caballos. (2021) Counterfeit formulations: analytical perspective on anorectics. Forensic Toxicology 39:1, pages 1-25.
Crossref
Crossref
Mi Lee, Ji Kim, Jun Choi, Jin Park, Hye Kim, Bo Song, Young Choi, Kyung Kim, Hyunkeun Song & Dae Hwang. (2019) Anti‑obesity effect in high‑fat‑diet‑induced obese C57BL/6 mice: Study of a novel extract from mulberry (Morus alba) leaves fermented with Cordyceps militaris. Experimental and Therapeutic Medicine.
Crossref
Crossref
Qin-Hu Sun, Yu Zhang & Gui-Xin Chou. (2017) Synthesis and anti-obesity effects in vivo of Crotadihydrofuran C as a novel PPARγ antagonist from Crotalaria albida. Scientific Reports 7:1.
Crossref
Crossref
Fatma Hadrich, Asma Mahmoudi, Zouhaier Bouallagui, Ines Feki, Hiroko Isoda, Bruno Feve & Sami Sayadi. (2016) Evaluation of hypocholesterolemic effect of oleuropein in cholesterol-fed rats. Chemico-Biological Interactions 252, pages 54-60.
Crossref
Crossref
Yoon-Young Sung, Dong-Seon Kim & Ho Kyoung Kim. (2014) Viola mandshurica ethanolic extract prevents high-fat-diet-induced obesity in mice by activating AMP-activated protein kinase. Environmental Toxicology and Pharmacology 38:1, pages 41-50.
Crossref
Crossref
YOON-YOUNG SUNG, TAESOOK YOON, WON-KYUNG YANG, BYEONG-CHEOL MOON & HO KYOUNG KIM. (2013) Anti-obesity effects of Actinidia polygama extract in mice with high-fat diet-induced obesity. Molecular Medicine Reports 7:2, pages 396-400.
Crossref
Crossref
Yoon-Young Sung, Taesook Yoon, Won-Kyung Yang, Seung Ju Kim, Dong-Seon Kim & Ho Kyoung Kim. (2013)
The Antiobesity Effect of
Polygonum aviculare
L. Ethanol Extract in High-Fat Diet-Induced Obese Mice
. Evidence-Based Complementary and Alternative Medicine 2013, pages 1-11.
Crossref
Crossref
Cecilia Nilsson, Kirsten Raun, Fei-fei Yan, Marianne O Larsen & Mads Tang-Christensen. (2012) Laboratory animals as surrogate models of human obesity. Acta Pharmacologica Sinica 33:2, pages 173-181.
Crossref
Crossref
Hsien-Yuan Lane, Guochuan E. Tsai & Eugene Lin. (2012) Assessing Gene-Gene Interactions in Pharmacogenomics. Molecular Diagnosis & Therapy 16:1, pages 15-27.
Crossref
Crossref
André J. Scheen. (2011) Sibutramine on Cardiovascular Outcome. Diabetes Care 34:Supplement_2, pages S114-S119.
Crossref
Crossref
Sherry Pagoto, Kristin Schneider, Bradley M. Appelhans, Carol Curtin & Alexandra Hajduk. 2011. Psychological Co-morbidities of Physical Illness. Psychological Co-morbidities of Physical Illness
1
72
.
A.J. Scheen. (2010) Cardiovascular Risk-Benefit Profile of Sibutramine. American Journal Cardiovascular Drugs 10:5, pages 321-334.
Crossref
Crossref
André J. Scheen. (2010) Controversy about the Cardiovascular Safety of Sibutramine. Drug Safety 33:7, pages 615-618.
Crossref
Crossref
M. Reiser, S. Eickmann, T. Haverkamp & U. Finckh. (2010) Variegate porphyria in a 46-year-old patient taking sibutramine for weight loss. Obesity Reviews 11:4, pages 329-331.
Crossref
Crossref
Tun-Jen Hsiao, Lawrence Shih-Hsin Wu, Yuchi Hwang, Shih-Yi Huang & Eugene Lin. (2012) Effect of the Common -866G/A Polymorphism of the Uncoupling Protein 2 Gene on Weight Loss and Body Composition under Sibutramine Therapy in an Obese Taiwanese Population. Molecular Diagnosis & Therapy 14:2, pages 101-106.
Crossref
Crossref
K A Kim, W K Song & J Y Park. (2009) Association of CYP2B6, CYP3A5, and CYP2C19 Genetic Polymorphisms With Sibutramine Pharmacokinetics in Healthy Korean Subjects. Clinical Pharmacology & Therapeutics 86:5, pages 511-518.
Crossref
Crossref
Dun-Jen Hsiao, Lawrence Shih-Hsin Wu, Shih-Yi Huang & Eugene Lin. (2009) Weight loss and body fat reduction under sibutramine therapy in obesity with the C825T polymorphism in the GNB3 gene. Pharmacogenetics and Genomics 19:9, pages 730-733.
Crossref
Crossref